 John Carroll
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 53 | 2023 | 152 | 13.630 |
Why?
| | Foramen Ovale, Patent | 33 | 2024 | 44 | 10.940 |
Why?
| | Cardiac Catheterization | 57 | 2024 | 536 | 10.780 |
Why?
| | Aortic Valve Stenosis | 45 | 2023 | 253 | 9.330 |
Why?
| | Heart Valve Prosthesis Implantation | 25 | 2023 | 169 | 6.350 |
Why?
| | Coronary Angiography | 31 | 2020 | 307 | 6.290 |
Why?
| | Septal Occluder Device | 21 | 2021 | 46 | 5.810 |
Why?
| | Heart Valve Prosthesis | 20 | 2022 | 118 | 5.190 |
Why?
| | Stroke | 33 | 2024 | 1016 | 4.990 |
Why?
| | Echocardiography, Transesophageal | 18 | 2021 | 89 | 4.770 |
Why?
| | Echocardiography, Three-Dimensional | 12 | 2019 | 48 | 4.700 |
Why?
| | Aortic Valve | 35 | 2023 | 342 | 4.330 |
Why?
| | Heart Septal Defects, Atrial | 11 | 2020 | 51 | 3.650 |
Why?
| | Mitral Valve | 16 | 2023 | 84 | 3.560 |
Why?
| | Imaging, Three-Dimensional | 24 | 2019 | 495 | 3.520 |
Why?
| | Registries | 35 | 2023 | 1770 | 3.460 |
Why?
| | Mitral Valve Insufficiency | 12 | 2023 | 63 | 3.300 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 16 | 2019 | 106 | 3.200 |
Why?
| | Radiography, Interventional | 13 | 2020 | 111 | 3.160 |
Why?
| | Heart Valve Diseases | 14 | 2019 | 116 | 2.850 |
Why?
| | Ultrasonography, Interventional | 10 | 2020 | 125 | 2.790 |
Why?
| | Secondary Prevention | 13 | 2024 | 223 | 2.530 |
Why?
| | Treatment Outcome | 76 | 2024 | 9159 | 2.490 |
Why?
| | Echocardiography, Doppler, Color | 8 | 2019 | 37 | 2.120 |
Why?
| | Embolism, Paradoxical | 7 | 2020 | 7 | 1.820 |
Why?
| | Angioplasty, Balloon, Coronary | 13 | 2010 | 146 | 1.710 |
Why?
| | Heart Defects, Congenital | 8 | 2020 | 659 | 1.700 |
Why?
| | Cardiac Surgical Procedures | 8 | 2023 | 413 | 1.660 |
Why?
| | Fluoroscopy | 10 | 2021 | 141 | 1.650 |
Why?
| | Humans | 189 | 2024 | 115587 | 1.570 |
Why?
| | Coronary Artery Disease | 11 | 2011 | 607 | 1.480 |
Why?
| | Prosthesis Implantation | 6 | 2019 | 139 | 1.480 |
Why?
| | Cardiology | 13 | 2023 | 260 | 1.410 |
Why?
| | Thoracic Surgery | 10 | 2021 | 105 | 1.310 |
Why?
| | Heart Diseases | 5 | 2019 | 330 | 1.290 |
Why?
| | Stents | 16 | 2011 | 475 | 1.260 |
Why?
| | Predictive Value of Tests | 20 | 2019 | 1805 | 1.250 |
Why?
| | Catheterization | 8 | 2010 | 159 | 1.250 |
Why?
| | Iatrogenic Disease | 3 | 2018 | 51 | 1.180 |
Why?
| | Heart Injuries | 4 | 2018 | 36 | 1.160 |
Why?
| | Hypoxia | 4 | 2020 | 937 | 1.160 |
Why?
| | Coronary Vessels | 8 | 2010 | 229 | 1.160 |
Why?
| | Prostheses and Implants | 6 | 2013 | 140 | 1.150 |
Why?
| | Cineangiography | 7 | 2009 | 16 | 1.140 |
Why?
| | Risk Factors | 40 | 2023 | 8697 | 1.130 |
Why?
| | Societies, Medical | 9 | 2020 | 684 | 1.040 |
Why?
| | Image Enhancement | 3 | 2013 | 173 | 1.040 |
Why?
| | Aged | 60 | 2023 | 19251 | 1.020 |
Why?
| | Aged, 80 and over | 35 | 2022 | 6417 | 1.020 |
Why?
| | Image Processing, Computer-Assisted | 8 | 2015 | 691 | 1.010 |
Why?
| | Radiation Dosage | 8 | 2016 | 139 | 1.010 |
Why?
| | Platelet Aggregation Inhibitors | 10 | 2024 | 399 | 1.000 |
Why?
| | Mitral Valve Stenosis | 4 | 2016 | 19 | 1.000 |
Why?
| | Male | 90 | 2023 | 55949 | 0.990 |
Why?
| | Ischemic Attack, Transient | 3 | 2015 | 61 | 0.980 |
Why?
| | Prosthesis Failure | 5 | 2020 | 116 | 0.970 |
Why?
| | Prosthesis Design | 13 | 2019 | 287 | 0.950 |
Why?
| | Coronary Stenosis | 3 | 2010 | 39 | 0.910 |
Why?
| | Sodium Chloride | 2 | 2015 | 136 | 0.910 |
Why?
| | Fibrinolytic Agents | 6 | 2022 | 233 | 0.890 |
Why?
| | Contrast Media | 6 | 2015 | 362 | 0.870 |
Why?
| | Female | 82 | 2023 | 59913 | 0.860 |
Why?
| | Percutaneous Coronary Intervention | 2 | 2020 | 445 | 0.850 |
Why?
| | Multimodal Imaging | 3 | 2020 | 98 | 0.850 |
Why?
| | United States | 42 | 2023 | 12295 | 0.840 |
Why?
| | Intracranial Embolism | 1 | 2022 | 29 | 0.830 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2392 | 0.820 |
Why?
| | Technology Transfer | 1 | 2021 | 13 | 0.780 |
Why?
| | Time Factors | 20 | 2022 | 6165 | 0.770 |
Why?
| | Randomized Controlled Trials as Topic | 10 | 2021 | 1216 | 0.740 |
Why?
| | Device Removal | 4 | 2012 | 128 | 0.730 |
Why?
| | Risk Assessment | 17 | 2021 | 2987 | 0.730 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 101 | 0.710 |
Why?
| | Embolism | 3 | 2019 | 43 | 0.700 |
Why?
| | Postoperative Complications | 11 | 2021 | 2161 | 0.690 |
Why?
| | Echocardiography | 9 | 2020 | 558 | 0.680 |
Why?
| | Surgery, Computer-Assisted | 4 | 2009 | 63 | 0.680 |
Why?
| | Middle Aged | 43 | 2022 | 26999 | 0.670 |
Why?
| | Coronary Occlusion | 1 | 2019 | 18 | 0.660 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2019 | 3 | 0.660 |
Why?
| | Lacerations | 1 | 2019 | 30 | 0.660 |
Why?
| | Migraine Disorders | 4 | 2021 | 83 | 0.650 |
Why?
| | Product Surveillance, Postmarketing | 4 | 2015 | 63 | 0.650 |
Why?
| | Atrial Fibrillation | 4 | 2020 | 325 | 0.640 |
Why?
| | Dyspnea | 1 | 2020 | 223 | 0.640 |
Why?
| | Shock, Cardiogenic | 1 | 2019 | 53 | 0.640 |
Why?
| | Technology Assessment, Biomedical | 2 | 2015 | 29 | 0.630 |
Why?
| | Balloon Occlusion | 3 | 2014 | 26 | 0.620 |
Why?
| | Thrombosis | 4 | 2012 | 302 | 0.610 |
Why?
| | Patient Selection | 10 | 2019 | 654 | 0.600 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.590 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 3 | 0.590 |
Why?
| | Papillary Muscles | 1 | 2017 | 14 | 0.590 |
Why?
| | Models, Cardiovascular | 3 | 2008 | 172 | 0.570 |
Why?
| | Radiographic Image Enhancement | 4 | 2009 | 58 | 0.560 |
Why?
| | Therapy, Computer-Assisted | 2 | 2014 | 58 | 0.560 |
Why?
| | Aorta | 3 | 2009 | 353 | 0.550 |
Why?
| | Severity of Illness Index | 11 | 2021 | 2578 | 0.550 |
Why?
| | Surgeons | 4 | 2022 | 238 | 0.550 |
Why?
| | Medicare | 8 | 2023 | 666 | 0.550 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2017 | 51 | 0.550 |
Why?
| | Multidetector Computed Tomography | 1 | 2016 | 26 | 0.540 |
Why?
| | Heart Ventricles | 3 | 2018 | 712 | 0.530 |
Why?
| | Aortography | 1 | 2016 | 48 | 0.530 |
Why?
| | Diagnostic Imaging | 3 | 2010 | 296 | 0.530 |
Why?
| | Exercise Test | 3 | 2015 | 539 | 0.520 |
Why?
| | Echocardiography, Stress | 1 | 2015 | 20 | 0.520 |
Why?
| | Consensus | 9 | 2021 | 532 | 0.510 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 44 | 0.490 |
Why?
| | Fistula | 2 | 2022 | 27 | 0.490 |
Why?
| | Retrospective Studies | 21 | 2021 | 12608 | 0.490 |
Why?
| | Embolization, Therapeutic | 2 | 2007 | 179 | 0.480 |
Why?
| | Radiation Injuries | 1 | 2015 | 127 | 0.470 |
Why?
| | Foreign-Body Migration | 2 | 2012 | 38 | 0.470 |
Why?
| | Reoperation | 6 | 2021 | 525 | 0.470 |
Why?
| | Hospital Mortality | 11 | 2021 | 779 | 0.470 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2009 | 39 | 0.470 |
Why?
| | Health Policy | 1 | 2017 | 334 | 0.470 |
Why?
| | Heart Septal Defects | 3 | 2008 | 10 | 0.460 |
Why?
| | Balloon Valvuloplasty | 1 | 2013 | 3 | 0.450 |
Why?
| | Incidence | 10 | 2021 | 2335 | 0.430 |
Why?
| | Reproducibility of Results | 12 | 2021 | 2800 | 0.420 |
Why?
| | Surgical Instruments | 1 | 2012 | 48 | 0.410 |
Why?
| | Aortic Rupture | 1 | 2012 | 25 | 0.410 |
Why?
| | Myocardial Infarction | 8 | 2008 | 931 | 0.400 |
Why?
| | Adult | 27 | 2023 | 30718 | 0.400 |
Why?
| | Prospective Studies | 14 | 2023 | 6264 | 0.390 |
Why?
| | Triiodobenzoic Acids | 2 | 2011 | 12 | 0.390 |
Why?
| | Models, Anatomic | 2 | 2009 | 92 | 0.390 |
Why?
| | Sensitivity and Specificity | 7 | 2019 | 1718 | 0.390 |
Why?
| | Coronary Restenosis | 2 | 2009 | 18 | 0.380 |
Why?
| | Catheter Ablation | 2 | 2018 | 291 | 0.380 |
Why?
| | Heart Atria | 5 | 2012 | 110 | 0.370 |
Why?
| | Computer Simulation | 4 | 2008 | 881 | 0.370 |
Why?
| | Angiography | 4 | 2019 | 177 | 0.360 |
Why?
| | Coronary Disease | 3 | 2009 | 348 | 0.360 |
Why?
| | Follow-Up Studies | 14 | 2019 | 4440 | 0.350 |
Why?
| | Equipment Design | 5 | 2014 | 517 | 0.350 |
Why?
| | Algorithms | 7 | 2010 | 1490 | 0.350 |
Why?
| | Coronary Thrombosis | 1 | 2009 | 25 | 0.330 |
Why?
| | Angiocardiography | 1 | 2009 | 1 | 0.330 |
Why?
| | Anticoagulants | 4 | 2021 | 549 | 0.330 |
Why?
| | Rotation | 4 | 2011 | 113 | 0.330 |
Why?
| | Evidence-Based Medicine | 4 | 2019 | 684 | 0.320 |
Why?
| | Oxygen | 1 | 2013 | 837 | 0.320 |
Why?
| | Survival Rate | 12 | 2021 | 1650 | 0.320 |
Why?
| | Myocardial Revascularization | 1 | 2009 | 67 | 0.320 |
Why?
| | Clinical Decision-Making | 4 | 2019 | 273 | 0.320 |
Why?
| | Stroke Volume | 2 | 2009 | 509 | 0.320 |
Why?
| | Drug-Eluting Stents | 1 | 2009 | 62 | 0.310 |
Why?
| | Recurrence | 7 | 2022 | 952 | 0.310 |
Why?
| | Practice Guidelines as Topic | 5 | 2019 | 1405 | 0.310 |
Why?
| | Echocardiography, Doppler | 1 | 2008 | 90 | 0.310 |
Why?
| | Migraine with Aura | 1 | 2008 | 10 | 0.310 |
Why?
| | Heart Septum | 1 | 2008 | 26 | 0.310 |
Why?
| | Ventricular Septum | 1 | 2007 | 9 | 0.300 |
Why?
| | Patient Simulation | 1 | 2008 | 29 | 0.300 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 39 | 0.300 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 196 | 0.290 |
Why?
| | Health Status | 3 | 2021 | 728 | 0.290 |
Why?
| | Hemodynamics | 6 | 2020 | 968 | 0.290 |
Why?
| | Pericardium | 1 | 2007 | 50 | 0.290 |
Why?
| | Clinical Competence | 6 | 2019 | 912 | 0.280 |
Why?
| | Catheters, Indwelling | 1 | 2007 | 79 | 0.280 |
Why?
| | Hemostatic Techniques | 1 | 2007 | 40 | 0.280 |
Why?
| | Advisory Committees | 2 | 2018 | 208 | 0.280 |
Why?
| | Cohort Studies | 7 | 2023 | 4944 | 0.270 |
Why?
| | Comprehension | 1 | 2008 | 158 | 0.270 |
Why?
| | Wounds, Penetrating | 1 | 2007 | 70 | 0.270 |
Why?
| | Hemorrhage | 4 | 2018 | 618 | 0.270 |
Why?
| | Patient Readmission | 4 | 2019 | 609 | 0.270 |
Why?
| | Recovery of Function | 3 | 2019 | 577 | 0.270 |
Why?
| | Equipment Failure | 3 | 2012 | 109 | 0.260 |
Why?
| | Ischemia | 1 | 2009 | 363 | 0.260 |
Why?
| | Aortic Diseases | 1 | 2007 | 95 | 0.260 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 467 | 0.260 |
Why?
| | Immunoglobulin Fab Fragments | 6 | 2008 | 69 | 0.250 |
Why?
| | Blood Vessel Prosthesis | 1 | 2006 | 113 | 0.250 |
Why?
| | Aneurysm, False | 1 | 2005 | 46 | 0.250 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2004 | 8 | 0.250 |
Why?
| | Aortic Aneurysm | 1 | 2005 | 50 | 0.250 |
Why?
| | Education, Medical | 1 | 2008 | 225 | 0.240 |
Why?
| | Equipment Safety | 1 | 2004 | 40 | 0.240 |
Why?
| | Healthcare Disparities | 2 | 2020 | 485 | 0.240 |
Why?
| | Antibodies, Antiphospholipid | 1 | 2004 | 21 | 0.230 |
Why?
| | Antiphospholipid Syndrome | 1 | 2004 | 26 | 0.230 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2003 | 12 | 0.220 |
Why?
| | Magnetic Resonance Angiography | 1 | 2005 | 209 | 0.220 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1180 | 0.220 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 366 | 0.210 |
Why?
| | Aspirin | 3 | 2020 | 326 | 0.210 |
Why?
| | Automation | 2 | 2016 | 74 | 0.210 |
Why?
| | Aneurysm | 1 | 2022 | 29 | 0.210 |
Why?
| | Embolic Protection Devices | 1 | 2022 | 11 | 0.210 |
Why?
| | Prognosis | 5 | 2021 | 3339 | 0.200 |
Why?
| | Pacemaker, Artificial | 2 | 2020 | 107 | 0.200 |
Why?
| | Hospitals, High-Volume | 2 | 2019 | 39 | 0.200 |
Why?
| | Multicenter Studies as Topic | 5 | 2023 | 249 | 0.200 |
Why?
| | Quality of Health Care | 3 | 2019 | 576 | 0.200 |
Why?
| | Renal Insufficiency | 1 | 2003 | 137 | 0.200 |
Why?
| | Arteries | 1 | 2003 | 250 | 0.200 |
Why?
| | Mycobacterium tuberculosis | 1 | 2004 | 271 | 0.200 |
Why?
| | Decompression Sickness | 1 | 2021 | 2 | 0.190 |
Why?
| | Cost-Benefit Analysis | 3 | 2019 | 548 | 0.190 |
Why?
| | Health Resources | 2 | 2019 | 122 | 0.190 |
Why?
| | Learning Curve | 2 | 2019 | 63 | 0.190 |
Why?
| | Observer Variation | 3 | 2011 | 297 | 0.180 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2014 | 154 | 0.180 |
Why?
| | Cardiovascular Agents | 3 | 2014 | 125 | 0.180 |
Why?
| | Colorado | 4 | 2019 | 4113 | 0.180 |
Why?
| | Databases, Factual | 3 | 2020 | 1138 | 0.180 |
Why?
| | American Heart Association | 2 | 2019 | 266 | 0.180 |
Why?
| | Thromboembolism | 1 | 2021 | 93 | 0.180 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2015 | 220 | 0.180 |
Why?
| | Rural Health Services | 1 | 2020 | 93 | 0.170 |
Why?
| | Computer Systems | 2 | 2009 | 46 | 0.170 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2019 | 231 | 0.170 |
Why?
| | Pattern Recognition, Automated | 3 | 2010 | 71 | 0.170 |
Why?
| | Antibodies, Monoclonal | 6 | 2008 | 1265 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 2 | 2007 | 3069 | 0.170 |
Why?
| | Cardiopulmonary Bypass | 1 | 2020 | 176 | 0.170 |
Why?
| | Neurologists | 1 | 2019 | 18 | 0.160 |
Why?
| | Hospitals, Low-Volume | 1 | 2019 | 22 | 0.160 |
Why?
| | Length of Stay | 3 | 2020 | 958 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Comparative Effectiveness Research | 1 | 2020 | 130 | 0.160 |
Why?
| | Popliteal Artery | 2 | 2009 | 59 | 0.160 |
Why?
| | Hospital Costs | 1 | 2019 | 105 | 0.160 |
Why?
| | Young Adult | 6 | 2021 | 10470 | 0.160 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 23 | 0.160 |
Why?
| | Heart Valves | 1 | 2019 | 41 | 0.160 |
Why?
| | Atrioventricular Block | 1 | 2019 | 37 | 0.160 |
Why?
| | Patient-Specific Modeling | 1 | 2019 | 37 | 0.160 |
Why?
| | Software | 2 | 2016 | 541 | 0.160 |
Why?
| | Treatment Failure | 3 | 2009 | 332 | 0.160 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2018 | 77 | 0.160 |
Why?
| | Angioplasty, Balloon | 2 | 2011 | 90 | 0.150 |
Why?
| | Bioprosthesis | 1 | 2018 | 34 | 0.150 |
Why?
| | Models, Organizational | 2 | 2019 | 143 | 0.150 |
Why?
| | Diagnostic Errors | 2 | 2010 | 151 | 0.150 |
Why?
| | Proportional Hazards Models | 3 | 2019 | 1087 | 0.150 |
Why?
| | Heart Block | 1 | 2018 | 38 | 0.150 |
Why?
| | Risk | 3 | 2019 | 819 | 0.150 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 180 | 0.150 |
Why?
| | Disease Management | 2 | 2021 | 563 | 0.150 |
Why?
| | Intention to Treat Analysis | 2 | 2017 | 69 | 0.150 |
Why?
| | Coronary Circulation | 2 | 2007 | 128 | 0.140 |
Why?
| | Research Report | 1 | 2017 | 76 | 0.140 |
Why?
| | France | 1 | 2016 | 34 | 0.140 |
Why?
| | Single-Blind Method | 2 | 2017 | 255 | 0.140 |
Why?
| | Personal Satisfaction | 1 | 2018 | 185 | 0.140 |
Why?
| | Patient Safety | 2 | 2019 | 276 | 0.140 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 152 | 0.130 |
Why?
| | Adolescent | 6 | 2021 | 17889 | 0.130 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.130 |
Why?
| | Radiation Exposure | 1 | 2016 | 41 | 0.130 |
Why?
| | Atrial Pressure | 1 | 2015 | 4 | 0.130 |
Why?
| | Heart Rate | 2 | 2011 | 701 | 0.130 |
Why?
| | Atrial Function, Right | 1 | 2015 | 13 | 0.130 |
Why?
| | Movement | 2 | 2009 | 246 | 0.130 |
Why?
| | Valsalva Maneuver | 1 | 2015 | 10 | 0.130 |
Why?
| | Netherlands | 1 | 2015 | 64 | 0.130 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2015 | 63 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 376 | 0.120 |
Why?
| | Area Under Curve | 1 | 2015 | 278 | 0.120 |
Why?
| | Intersectoral Collaboration | 1 | 2015 | 56 | 0.120 |
Why?
| | Patient Care Team | 1 | 2019 | 521 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2020 | 771 | 0.120 |
Why?
| | Ultrasonography | 2 | 2008 | 641 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2015 | 234 | 0.120 |
Why?
| | Four-Dimensional Computed Tomography | 1 | 2014 | 25 | 0.120 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 490 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 451 | 0.110 |
Why?
| | Cardiac Catheters | 1 | 2013 | 15 | 0.110 |
Why?
| | Atrial Septum | 1 | 2013 | 3 | 0.110 |
Why?
| | Global Health | 1 | 2016 | 290 | 0.110 |
Why?
| | Punctures | 1 | 2013 | 37 | 0.110 |
Why?
| | X-Rays | 2 | 2010 | 31 | 0.110 |
Why?
| | Societies | 1 | 2013 | 39 | 0.110 |
Why?
| | Propensity Score | 3 | 2019 | 225 | 0.110 |
Why?
| | Blood Pressure | 2 | 2011 | 1537 | 0.110 |
Why?
| | Hospitals | 1 | 2017 | 585 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2004 | 1724 | 0.100 |
Why?
| | Forecasting | 2 | 2016 | 333 | 0.100 |
Why?
| | Femoral Artery | 2 | 2013 | 167 | 0.100 |
Why?
| | United States Food and Drug Administration | 1 | 2013 | 173 | 0.100 |
Why?
| | Models, Statistical | 1 | 2016 | 606 | 0.100 |
Why?
| | Research Design | 1 | 2018 | 946 | 0.100 |
Why?
| | Quality Improvement | 2 | 2019 | 958 | 0.100 |
Why?
| | Electrocardiography | 2 | 2014 | 560 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2004 | 180 | 0.100 |
Why?
| | Europe | 2 | 2009 | 336 | 0.100 |
Why?
| | Stress, Mechanical | 2 | 2003 | 440 | 0.090 |
Why?
| | Automation, Laboratory | 1 | 2010 | 7 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 636 | 0.090 |
Why?
| | Heart | 1 | 2014 | 608 | 0.090 |
Why?
| | Radiology, Interventional | 1 | 2010 | 28 | 0.090 |
Why?
| | Hospitals, Veterans | 1 | 2011 | 245 | 0.090 |
Why?
| | Mitral Valve Prolapse | 1 | 2009 | 8 | 0.090 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 34 | 0.080 |
Why?
| | Cause of Death | 3 | 2018 | 368 | 0.080 |
Why?
| | Artifacts | 2 | 2009 | 122 | 0.080 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2009 | 30 | 0.080 |
Why?
| | Prevalence | 2 | 2018 | 2264 | 0.080 |
Why?
| | Patient Reported Outcome Measures | 2 | 2021 | 250 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2019 | 5077 | 0.080 |
Why?
| | Peripheral Vascular Diseases | 1 | 2009 | 98 | 0.080 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 135 | 0.080 |
Why?
| | Artificial Intelligence | 2 | 2010 | 148 | 0.080 |
Why?
| | Ticlopidine | 1 | 2008 | 55 | 0.080 |
Why?
| | Heart Failure | 2 | 2018 | 1963 | 0.080 |
Why?
| | Nose | 1 | 2008 | 56 | 0.080 |
Why?
| | Robotics | 1 | 2009 | 78 | 0.080 |
Why?
| | Linear Models | 1 | 2010 | 776 | 0.080 |
Why?
| | Leg | 1 | 2009 | 227 | 0.080 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2005 | 20 | 0.070 |
Why?
| | Phantoms, Imaging | 2 | 2010 | 134 | 0.070 |
Why?
| | Endpoint Determination | 1 | 2008 | 69 | 0.070 |
Why?
| | Motion | 2 | 2010 | 94 | 0.070 |
Why?
| | Wakefulness | 1 | 2008 | 128 | 0.070 |
Why?
| | Sirolimus | 1 | 2009 | 192 | 0.070 |
Why?
| | Cardiac Tamponade | 1 | 2007 | 14 | 0.070 |
Why?
| | Injections | 1 | 2007 | 161 | 0.070 |
Why?
| | Age Factors | 2 | 2020 | 2907 | 0.070 |
Why?
| | Quality Indicators, Health Care | 2 | 2019 | 287 | 0.070 |
Why?
| | Thoracotomy | 1 | 2006 | 67 | 0.070 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2006 | 99 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2008 | 1660 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1031 | 0.060 |
Why?
| | Muramic Acids | 1 | 2004 | 1 | 0.060 |
Why?
| | Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2004 | 12 | 0.060 |
Why?
| | Peptidoglycan | 1 | 2004 | 25 | 0.060 |
Why?
| | Ions | 1 | 2004 | 61 | 0.060 |
Why?
| | Cell Wall | 1 | 2004 | 50 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2007 | 741 | 0.060 |
Why?
| | Quality of Life | 3 | 2021 | 2385 | 0.060 |
Why?
| | Open Reading Frames | 1 | 2004 | 116 | 0.060 |
Why?
| | Probability | 1 | 2005 | 294 | 0.060 |
Why?
| | Whole-Body Irradiation | 1 | 2004 | 72 | 0.060 |
Why?
| | Genome, Bacterial | 1 | 2004 | 106 | 0.060 |
Why?
| | Informed Consent | 1 | 2005 | 161 | 0.060 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2004 | 39 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 815 | 0.060 |
Why?
| | Shear Strength | 1 | 2003 | 55 | 0.060 |
Why?
| | Thrombocytopenia | 1 | 2005 | 175 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2004 | 523 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1357 | 0.060 |
Why?
| | Thrombophilia | 1 | 2004 | 66 | 0.060 |
Why?
| | Catheters | 1 | 2023 | 66 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2005 | 212 | 0.050 |
Why?
| | Patient Care Planning | 1 | 2003 | 142 | 0.050 |
Why?
| | Elasticity | 1 | 2003 | 194 | 0.050 |
Why?
| | Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| | Japan | 1 | 2022 | 88 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 1918 | 0.050 |
Why?
| | Creatinine | 1 | 2003 | 430 | 0.050 |
Why?
| | Curriculum | 1 | 2008 | 852 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 334 | 0.050 |
Why?
| | Patient-Centered Care | 1 | 2006 | 477 | 0.050 |
Why?
| | Child | 2 | 2012 | 18488 | 0.050 |
Why?
| | Patient Discharge | 2 | 2004 | 770 | 0.050 |
Why?
| | Acute Disease | 1 | 2003 | 914 | 0.050 |
Why?
| | Escherichia coli | 1 | 2004 | 730 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 962 | 0.050 |
Why?
| | Base Sequence | 1 | 2004 | 2114 | 0.050 |
Why?
| | Computational Biology | 1 | 2004 | 536 | 0.050 |
Why?
| | Florida | 1 | 2020 | 73 | 0.050 |
Why?
| | Syndrome | 1 | 2021 | 339 | 0.040 |
Why?
| | Population Density | 1 | 2020 | 94 | 0.040 |
Why?
| | Norepinephrine | 1 | 2001 | 207 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2790 | 0.040 |
Why?
| | Decision Making | 1 | 2006 | 791 | 0.040 |
Why?
| | Epinephrine | 1 | 2001 | 167 | 0.040 |
Why?
| | Travel | 1 | 2020 | 121 | 0.040 |
Why?
| | Cost Savings | 1 | 2019 | 75 | 0.040 |
Why?
| | Cardiac Care Facilities | 1 | 2019 | 13 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2021 | 538 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2020 | 186 | 0.040 |
Why?
| | Cardiac Imaging Techniques | 1 | 2019 | 13 | 0.040 |
Why?
| | Credentialing | 1 | 2019 | 12 | 0.040 |
Why?
| | Trauma Severity Indices | 1 | 2019 | 111 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2001 | 293 | 0.040 |
Why?
| | Child, Preschool | 1 | 2012 | 9133 | 0.040 |
Why?
| | Renin-Angiotensin System | 1 | 2018 | 72 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 88 | 0.040 |
Why?
| | Models, Econometric | 1 | 2018 | 34 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2020 | 276 | 0.040 |
Why?
| | Inpatients | 2 | 2016 | 380 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 89 | 0.040 |
Why?
| | Markov Chains | 1 | 2018 | 114 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 744 | 0.040 |
Why?
| | Workload | 1 | 2019 | 133 | 0.040 |
Why?
| | United Kingdom | 1 | 2018 | 227 | 0.040 |
Why?
| | Altitude | 1 | 2001 | 409 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 2018 | 126 | 0.040 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 315 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 290 | 0.030 |
Why?
| | Biomarkers | 1 | 2006 | 3466 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2019 | 369 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1219 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 519 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2016 | 204 | 0.030 |
Why?
| | Medicaid | 1 | 2018 | 411 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1473 | 0.030 |
Why?
| | Spatio-Temporal Analysis | 1 | 2014 | 27 | 0.030 |
Why?
| | Venous Thromboembolism | 1 | 2017 | 234 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1856 | 0.030 |
Why?
| | Radiation | 1 | 2013 | 24 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 210 | 0.020 |
Why?
| | Exercise | 1 | 2001 | 1609 | 0.020 |
Why?
| | Combined Modality Therapy | 2 | 2005 | 1127 | 0.020 |
Why?
| | Torsion, Mechanical | 1 | 2009 | 7 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 585 | 0.020 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 118 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 127 | 0.020 |
Why?
| | Posture | 1 | 2009 | 150 | 0.020 |
Why?
| | Radiography | 1 | 2010 | 826 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 237 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2009 | 677 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 262 | 0.020 |
Why?
| | Platelet Count | 1 | 2005 | 83 | 0.020 |
Why?
| | Age Distribution | 1 | 2005 | 341 | 0.010 |
Why?
| | Sex Distribution | 1 | 2005 | 337 | 0.010 |
Why?
| | Patient Admission | 1 | 2004 | 175 | 0.010 |
Why?
| | Odds Ratio | 1 | 2005 | 962 | 0.010 |
Why?
| | Heparin | 1 | 2003 | 227 | 0.010 |
Why?
| | Myocardial Reperfusion | 1 | 2002 | 51 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2003 | 434 | 0.010 |
Why?
| | Postoperative Care | 1 | 2003 | 222 | 0.010 |
Why?
| | Prazosin | 1 | 2001 | 26 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 29 | 0.010 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2001 | 30 | 0.010 |
Why?
| | Phenylephrine | 1 | 2001 | 75 | 0.010 |
Why?
| | Health Care Costs | 1 | 2003 | 384 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 573 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|